High levels of BCL-XL driven by STAT5 have been implicated in the resistance of BCR/ABL+ chronic myelogenous leukaemia (CML) to apoptosis [199]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.